Literature DB >> 11389006

Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis.

S Fargion1, L Valenti, P Dongiovanni, A Scaccabarozzi, A L Fracanzani, E Taioli, M Mattioli, M Sampietro, G Fiorelli.   

Abstract

Severe iron overload usually develops in patients with hereditary hemochromatosis (HHC), but variability in the phenotypic expression of the disease has been reported. This study assessed whether tumor necrosis factor alpha (TNF-alpha) plays a role in phenotypic expression of HHC. Sixty-four patients with HHC and 172 healthy volunteers (controls) were studied. Release of TNF-alpha from stimulated peripheral blood monocytes was measured by enzyme-linked immunosorbent assay, and 308 and 238 TNF-alpha polymorphisms were detected with polymerase chain reaction and restriction fragment-length polymorphism analysis. The relation between TNF-alpha polymorphisms and clinical expression of HHC was evaluated. Patients with HHC released less TNF-alpha than controls, but the difference was significant only in homozygotes for the C282Y mutation. The prevalence of the 308 TNF-alpha polymorphism was similar in patients and controls, whereas the prevalence of the 238 polymorphic allele was significantly lower in patients (3% versus 16%; P =.002). A lower prevalence of cirrhosis was observed in patients with TNF-alpha polymorphism than in those without it (4 of 15 [27%] versus 28 of 49 [57%]), but the difference was not significant (P =.07). In nonhomozygotes for the C282Y mutation, severe liver siderosis was less prevalent in patients with the 308 polymorphism than in those without it (P =.05). Alanine aminotransferase (ALT) values were significantly lower in patients with TNF-alpha polymorphism (P =.006), even when patients with other hepatotoxic factors were excluded. Multivariate analysis showed that TNF-alpha polymorphism was independently associated with ALT values (P =.0008 and P =.045, respectively, in homozygotes and nonhomozygotes for the C282Y mutation) and siderosis in nonhomozygotes (P =.047). Thus, TNF-alpha appears to play a role in HHC by modulating the severity of liver damage. (Blood. 2001;97:3707-3712)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389006     DOI: 10.1182/blood.v97.12.3707

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.

Authors:  Ronald T Acton; James C Barton; Catherine Leiendecker-Foster; Christopher Zaun; Christine E McLaren; John H Eckfeldt
Journal:  Blood Cells Mol Dis       Date:  2010-02-23       Impact factor: 3.039

2.  Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.

Authors:  Luca Valenti; Paolo Maggioni; Alberto Piperno; Raffaela Rametta; Sara Pelucchi; Raffaella Mariani; Paola Dongiovanni; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

3.  Clinical penetrance of C282Y homozygous HFE haemochromatosis.

Authors:  Enrico Rossi; Gary P Jeffrey
Journal:  Clin Biochem Rev       Date:  2004-08

4.  Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.

Authors:  Paola Dongiovanni; Anna Ludovica Fracanzani; Gaetano Cairo; Chiara Paola Megazzini; Stefano Gatti; Raffaela Rametta; Silvia Fargion; Luca Valenti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

5.  Association of tumor necrosis factor genetic polymorphism with chronic atrophic gastritis and gastric adenocarcinoma in Chinese Han population.

Authors:  Bao-Ying Fei; Bing Xia; Chang-Sheng Deng; Xiao-Qing Xia; Min Xie; J Bart A Crusius; A Salvador Pena
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

Review 6.  Screening for hemochromatosis: patients with liver disease, families, and populations.

Authors:  Sumedha P Galhenage; Charlie H Viiala; John K Olynyk
Journal:  Curr Gastroenterol Rep       Date:  2004-02

Review 7.  Recent advances in understanding haemochromatosis: a transition state.

Authors:  K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

8.  Genetic polymorphisms of inflammatory response gene TNF-α and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk.

Authors:  Dimitrios Karakaxas; Maria Gazouli; Ahmet Coker; Christos Agalianos; Ioannis S Papanikolaou; Pavlos Patapis; Theodoros Liakakos; Christos Dervenis
Journal:  Med Oncol       Date:  2014-09-12       Impact factor: 3.064

9.  High expression of TNF alpha is associated with -308 and -238 TNF alpha polymorphisms in knee osteoarthritis.

Authors:  José Francisco Muñoz-Valle; Edith Oregón-Romero; Héctor Rangel-Villalobos; Gloria Esther Martínez-Bonilla; Eduardo Castañeda-Saucedo; Lorenzo Salgado-Goytia; Marco Antonio Leyva-Vázquez; Berenice Illades-Aguiar; Luz del Carmen Alarcón-Romero; Mónica Espinoza-Rojo; Isela Parra-Rojas
Journal:  Clin Exp Med       Date:  2012-10-30       Impact factor: 3.984

10.  Association between tumor necrosis factor-α rs1800629 polymorphism and risk of gastric cancer: a meta-analysis.

Authors:  Feng Zhu; Hang Zhao; Xiaohui Tian; Xiangjun Meng
Journal:  Tumour Biol       Date:  2013-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.